Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.

Howard A BurrisArlene ChanAditya BardiaJ Thaddeus BeckJoohyuk SohnPatrick NevenDebasish Tripathy Seock-Ah ImStephen ChiaFrancisco J EstevaLowell HartJuan Pablo ZarateAntonia RidolfiKaren Rodriguez LorencDenise A Yardley

Published in: British journal of cancer (2021)

MONALEESA-2 (NCT01958021) first posted October 8, 2013; MONALEESA-3 (NCT02422615) first posted April 21, 2015; MONALEESA-7 (NCT02278120) first posted October 29, 2014.

Keyphrases

clinical trial
open label
study protocol
randomized controlled trial